Skip to main content
Move the World.
Personal Genetics Might Solve the Opioid Crisis – and the Pain Crisis
Credit: Unsplash/rawpixel

Anyone who came of age in the 1990s remembers the “Friends” episode where Phoebe and Rachel venture out to get tattoos. Spoiler alert: Rachel gets a tattoo and Phoebe ends up with a black ink dot because she couldn’t take the pain. This sitcom storyline is funny, but it also simply illustrates the question that I and many others in the field ofpain geneticsare trying to answer. What is it about Rachel that makes her different from Phoebe? And, more importantly, can we harness this difference to help the “Phoebes” of the world suffer less by making them more like the “Rachels”?

Pain is the single most common symptom reported when seeking medical attention. Under normal circumstances, pain signals injury, and the natural response is to protect ourselves until we have recovered and the pain subsides. Unfortunately, people differ not only in their ability to detect, tolerate and respond to pain but also in how they report it and how they respond to various treatments. This makes it difficult to know how to effectively treat each patient. So, why isn’t pain the same in everyone?

Individual differences in health outcomes often result from complex interactions of psychosocial, environmental and genetic factors. While pain may not register as a traditional disease like heart disease or diabetes, the same constellation of factors are at play. The painful experiences throughout our lifetime occur against a background of genes that make us more or less sensitive to pain. But our mental and physical state, previous experiences – painful, traumatic – and the environment can modulate our responses.

If we can better understand what makes individuals more or less sensitive to pain in all kinds of situations, then we are that much closer to reducing human suffering by developing targeted personalized pain treatments with lower risks of misuse, tolerance and abuse than the current treatments. Ultimately, this would mean knowing who is going to have more pain or need more pain-killing drugs, and then being able to effectively manage that pain so the patient is more comfortable and has a quicker recovery.

Not all pain genes are the same

With the sequencing of the human genome, we know a lot about the number and location of genes that make up our DNA code. Millions of small variations within those genes have also been identified, some that have known effects and some that don’t.

These variations can come in a number of forms, but the most common variation is the single nucleotide polymorphism – SNP, pronounced “snip” – representing a single difference in the individual units that make up DNA.

There are approximately 10 million known SNPs in the human genome; an individual’s combination of SNPs makes up his or her personal DNA code and differentiates it from that of others. When a SNP is common, it is referred to as a variant; when a SNP is rare, found in less than 1 percent of the population, then it is called a mutation. Rapidly expanding evidence implicates dozens of genes and variants in determining our pain sensitivity, how well analgesics – like opioids – reduce our pain and even our risk for developing chronic pain.

A history of pain tolerance

The first studies of “pain genetics” were of families with an extremely rare condition characterized by the absence of pain. The first report of congenital insensitivity to pain described “pure analgesia” in a performer working in a traveling show as “The Human Pincushion.” In the 1960s there were reports of genetically related families with children who were pain-tolerant.

At that time the technology did not exist to determine the cause of this disorder, but from these rare families we know that CIP – now known by wonkier names like Channelopathy-associated insensitivity to pain and Hereditary Sensory and Autonomic Neuropathy – is the result of specific mutations or deletions within single genes required for transmitting pain signals.

The most common culprit is one of a small number of SNPs within SCN9A, a gene that encodes a protein channel necessary for sending pain signals. This condition is rare; only a handful of cases have been documented in the United States. While it might seem like a blessing to live without pain, these families must be always on alert for severe injuries or fatal illnesses. Typically children fall down and cry, but, in this case, there’s no pain to differentiate between a scraped knee and a broken knee cap. Pain insensitivity means that there is no chest pain signaling a heart attack and no lower right abdominal pain hinting at appendicitis, so these can kill before anyone knows that there is something wrong.

Supersensitivity to pain

Variations within SCN9A not only cause pain insensitivity, but have also been shown to trigger two severe conditions characterized by extreme pain: primary erythermalgia and paroxysmal extreme pain disorder. In these cases, the mutations within SCN9A cause more pain signals than normal.

These types of heritable pain conditions are extremely rare and, arguably, these studies of profound genetic variations reveal little about more subtle variations that may contribute to individual differences in the normal population.

However, with the growing public acceptance of genome-based medicine and calls for more precise personalized health care strategies, researchers are translating these findings into personalized pain treatment protocols that match a patient’s genes.

Do genetic variations affect pain in everyone?

We know some of the major genes that influence pain perception and new genes are being identified all the time.

The SCN9A gene is a major player in controlling the body’s response to pain by activating or silencing the sodium channel. But whether it amplifies or dampens pain depends on the mutation an individual carries.

Estimates suggest that up to 60 percent of the variability in pain is the result of inherited – that is, genetic – factors. Stated simply, this means that pain sensitivity runs in families through normal genetic inheritance, much like height, hair color or skin tone.

Turns out that SCN9A also plays a role in pain in the normal population. A relatively more common SNP within SCN9A, called 3312G>T which occurs in 5 percent of the population, has been shown to determine sensitivity to post-operative pain and how much opioid medication is needed to control it. Another SNP in SCN9A gene causes greater sensitivity for those with pain caused by osteoarthritis, lumbar disc removal surgery, amputee phantom limbs and pancreatitis.

New painkillers from sea creatures

Puffer fish, like <em>Arothron meleagris</em> can produce a toxin blocks the transmission of pain signals.

Puffer fish, like Arothron meleagris can produce a toxin blocks the transmission of pain signals. Credit: NPS photo - Bill Eichenlaub

Therapeutically, we have been using local anesthetics, including lidocaine, to treat pain by inducing a short term block of the channel to stop pain transmission. These drugs have been continuously used to safely and effectively block pain for more than a century.

Interestingly, researchers are evaluating tetrodotoxin, a potent neurotoxin produced by sea creatures like pufferfish and octopuses, which works by blocking pain signal transmission, as a potential pain killer. They have shown early efficacy in treating cancer pain and migraine. These drugs and toxins induce the same state that is present in those with congenital insensitivity to pain.

If there’s one silver lining to the opioid crisis, it is the realization that we need more precise tools to treat pain – ones that treat pain at the source and come with fewer side effects and risk. By understanding the genetic contribution to pain sensitivity, susceptibility to chronic pain and even analgesic response, we can then design treatments that address the “why” of pain and not just the “"where.” We’re beginning to design precision pain management strategies already, and the benefit to humankind will only increase as we know more about why pain differs among people.The Conversation

Erin Young is an Assistant Professor at the UCONN School of Nursing and an Assistant Director of the UCONN Center for Advancement in Managing Pain. This article was originally published at The Conversation.

Up Next

State of Surveillance
New Tech Can See Through Walls and ID People by the Way They Walk
gait recognition
State of Surveillance
New Tech Can See Through Walls and ID People by the Way They Walk
A California-based lab is using gait recognition and radio frequency to create a surveillance system that can see behind walls.

A California-based lab is using gait recognition and radio frequency to create a surveillance system that can see behind walls.

#fixingjustice - Harm Reduction
Why Drugs Are Hurting More People Than Ever – And What to Do About It
Why Drugs Are Hurting More People Than Ever – And What to Do About It
#fixingjustice - Harm Reduction
Why Drugs Are Hurting More People Than Ever – And What to Do About It
Is the solution to dangerous drugs... making them safer?

Is the solution to dangerous drugs... making them safer?

Dispatches
Tiny Satellite “Constellations” Could Bring the Entire World Online
Tiny Satellite “Constellations” Could Bring the Entire World Online
Dispatches
Tiny Satellite “Constellations” Could Bring the Entire World Online
SpaceX is out in front, but the race for global satellite internet is getting crowded.

SpaceX is out in front, but the race for global satellite internet is getting crowded.

Dispatches
Training the Body to Fight Off Drug-Resistant Bacteria
Training the Body to Fight Off Drug-Resistant Bacteria
Dispatches
Training the Body to Fight Off Drug-Resistant Bacteria
A new strategy, called host-targeted defense, could help solve antibiotic resistance by upgrading the immune system.
By Zahidul Alam

A new strategy, called host-targeted defense, could help solve antibiotic resistance by upgrading the immune system.

Dispatches
Supercharging Photosynthesis Can Grow 40% More Food
Supercharging Photosynthesis Can Grow 40% More Food
Dispatches
Supercharging Photosynthesis Can Grow 40% More Food
We need a lot more calories to feed a growing world, and these scientists may have figured out how to get them.
By Amanda Cavanagh

We need a lot more calories to feed a growing world, and these scientists may have figured out how to get them.

Dispatches
How Redesigning Labs Can Demystify Genetic Science
How Redesigning Labs Can Demystify Genetic Science
Dispatches
How Redesigning Labs Can Demystify Genetic Science
"Scientists work in high-security buildings that are banned to the public and then wonder why they are misunderstood."
By Brook Muller

"Scientists work in high-security buildings that are banned to the public and then wonder why they are misunderstood."

Fighting Superbugs with Viruses
Fighting Superbugs with Viruses
Watch Now
Fighting Superbugs with Viruses
This Yale scientist's experimental treatment is a Texas woman's last resort.
Watch Now

Ben Chan searches sewers, lakes, and pig farms all around the world for bacteriophages (bacteria-destroying viruses) that could help fight antibiotic-resistant bacteria, also known as “superbugs.” Paige is a young woman in Texas with cystic fibrosis who is suffering from a drug-resistant infection; Ben’s experimental phage therapy is her last resort. We follow Ben as he travels from his laboratory at Yale to Lubbock,...

Dispatches
How Coffee Could Treat Diabetes
How Coffee Could Treat Diabetes
Dispatches
How Coffee Could Treat Diabetes
Someday, diabetics could use caffeine to trigger insulin production, thanks to specially designed kidney cells.

Someday, diabetics could use caffeine to trigger insulin production, thanks to specially designed kidney cells.

Superhuman
Reprogramming Your Immune System to Fight Cancer
Reprogramming Your Immune System to Fight Cancer
Watch Now
Superhuman
Reprogramming Your Immune System to Fight Cancer
Your T cells already know how to kill cancer. These doctors can train them to hunt it down.
Watch Now

Josh Feldman was on his honeymoon when he felt a lump on his neck. Returning home after the best month of his life, his doctor gave him the news: non-Hodgkin's lymphoma. There was no cure, and it was about to get much worse. After multiple rounds of chemotherapy failed to stop his tumors from growing, Josh went to see Dr. John Timmerman, an oncologist at UCLA who is trying something different, known as immunotherapy. This...

Superhuman
Using Virtual Reality to Help Kids with Autism
Using Virtual Reality to Help Kids with Autism
Watch Now
Superhuman
Using Virtual Reality to Help Kids with Autism
A virtual world offers a new way to engage with kids on the spectrum.
Watch Now

When their autistic son fell in love with a virtual reality headset, Vibha and Vijay Ravindran got an idea: could this unlimited digital world help people who have trouble engaging in the physical world? Together, they founded a company called Floreo to develop VR programs for people with developmental disabilities, helping them break free from the constraints of their bodies and the typical pressures of their learning...